Nihon University Working Group Study of Low-Dose hANP Infusion Therapy During Cardiac Surgery Trial for Chronic Kidney Disease - NU-HIT Trial for CKD


The goal of the trial was to evaluate perioperative infusion of human atrial natriuretic peptide (hANP) compared with placebo among patients with chronic renal insufficiency undergoing coronary artery bypass grafting (CABG).